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n INTRODUCTION
Early diagnosis of acute human immunode-ficiency virus (HIV) infection by rapid HIV 
tests allows identification of patients who may 
be candidates for antiretroviral treatment, quick 
confirmation of HIV status in patients presenting 
with an AIDS-defining illness and prevention of 
the spread of HIV infection [1, 2]. 
“Fourth-generation or combo” rapid tests (detect-
ing both antibodies and p24 antigen) have recent-
ly been found to be less accurate in identifying the 
acute phase of HIV infection in respect of conven-
tional “fourth-generation” tests [3, 4]. 
We report our experience in a patient with acute 
HIV infection (Fiebig III stage), in whom the rapid 
Alere Determine HIV 1/2 Ag/Ab Combo assay 
(Alere, Milan,Italy) test became positive only two 
weeks after the first positivity of conventional 
“fourth generation” immunoassays and over 30 
days after HIV exposure [5, 6].
n CASE REPORT
A 20-year-old man was admitted at the Infectious 
Diseases Unit, G.B. Rossi Hospital in Verona (Ita-
ly) in December 2013. He had been hospitalised 
elsewhere two days earlier with a one week his-
tory of fever, sore throat, arthromyalgias and fa-
tigue, and found to be HIV-infected by Ag P24/
Ab anti-HIV 1-2: CLIA assay (ADVIA CENTAUR 
HIV AG/AB COMBO, Siemens Healthcare Diag-
nostics Inc., USA) and ELFA assay (VIDAS HIV 
DUO, Quick bioMérieux, France). The patient 
had had unprotected sexual intercourse with an 
HIV-infected man 10 days prior to the onset of 
symptoms. When he presented to us he had fever 
(40°C), sore throat, arthralgias and headache. On 
physical examination a trunk macular rash and 
bilaterally palpable, tender cervical and inguinal 
lymph nodes were present. Blood tests showed 
anemia, leukopenia and increased transaminases. 
At arrival in our Unit the Alere Determine HIV 
1/2 Ag/Ab Combo test on whole blood was 
negative, while ADVIA CENTAUR HIV AG/AB 
COMBO and VIDAS HIV DUO were positive on 
serum. HIV1 and 2 immunoblot on serum (INNO-
LIA HIV-1/2, Innogenetics N.V., Belgium) was 
also negative. The first positive result of the rap-
id test Alere Determine on whole blood (Ag p24 
Performance of Alere Determine  
HIV-1/2 Ag/Ab Combo rapid test  
for acute HIV infection:  
a case report
Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo 
nell’infezione acuta da HIV: un caso clinico
Massimiliano Lanzafame1, Antonella Zorzi2, Fabio Rigo1, Irene Adami1, Paola Del Bravo1, 
Elisabetta Tonolli2, Ercole Concia1, Anna Maria Azzini1
1Unit of Infectious Diseases, Department of General Medicine, Azienda Ospedaliera Universitaria Integrata, 
Verona, Italy; 
2Unit of Microbiology, Department of Pathology and Diagnostics, Azienda Ospedaliera Universitaria Integrata, 
Verona, Italy
49Performance of Alere Determine HIV-1/2 Ag/Ab Combo rapid test for acute HIV infection
negative and HIV antibodies positive) was two 
weeks after admission (31 days after the likely 
acquisition of HIV infection), when Immunoblot 
became indeterminate (positivity for antibodies 
to -gp41 and p31) for the first time. Immunoblot 
was positive late in January 2014. At admission 
the patient had a viral load >10,000,000 copies/
mL and a CD4 cell count of 188 cells/µL (Table 1). 
We had started HAART (tenofovir/emtricitabine, 
atazanavir, ritonavir) three days after admission 
and 45 days later the CD4 cell count had risen to 
610/µL while HIV RNA had decreased to 1,310 
copies/mL.
n DISCUSSION
Alere Determine™ HIV-1/2 Ag/Ab Combo is a 
fourth generation assay capable of detecting HIV-
1 p24 antigen and HIV-1 and HIV-2 antibodies in 
serum, plasma and whole blood; it is therefore a 
conventional lateral flow rapid test device [6].
The sensitivity, as listed in the Alere Determine 
Combo package insert, is 99.9% using serum, 
plasma, and whole blood, while the specificity 
using all specimen types (serum, plasma, whole 
blood) is 100% for low risk subjects and ranges 
from 98.9% (serum) to 99.7% (whole blood) for 
high risk subjects [6]. 
CDC studies comparing all the FDA-approved 
tests on the same plasma specimens collected 
from persons during seroconversion found that 
Determine Combo detects infection one to two 
weeks before other rapid tests, and three to four 
days after fourth-generation laboratory antigen/
antibody HIV tests [7]. Despite the industry in-
dications, currently there are limited data on the 
relative sensitivity of Alere Determine Combo 
or other rapid HIV tests used with whole blood 
specimens like in our case. 
International studies using Alere Determine 
Combo indicate that antibody sensitivity is com-
parable to package insert specifications, but that 
the antigen component does not detect most acute 
infections demonstrated by laboratory 4th genera-
tion p24 antigen/antibody immunoassays [8-10]. 
Alere Determine Combo can become reactive ear-
lier than Western blot. 
Our case indicates the inability of Alere Deter-
mine HIV 1/2 Ag/Ab Combo test to diagnose 
primary HIV infection during the earliest phase. 
Also, we did not find a correlation between a viral 
load > 10,000,000 copies/mL and a positive Alere 
Determine HIV 1/2 Ag/Ab Combo test, contrary 
to as the report by Faraoni and colleagues, prob-
ably because they tested serum samples [4]. Our 
data suggest that when acute HIV infection is 
suspected, a rapid test should be supplemented 
by conventional “fourth generation” tests and/or 
plasma HIV RNA assay. 
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Table 1 - Days  after sexual exposure and temporal trend of laboratory tests.
Days after 
sexual 
exposure
Laboratory tests
Alere Determine TM HIV-1/2  
Ag/Ab Combo
ADVIA 
CENTAUR 
HIV 
VIDAS HIV 
DUO 
INNO-LIA HIV-1/2 HIV-RNA (copies/mL)
Ag p24 Antibodies
17 days not performed not performed + + negative not performed
18 days - - + + negative >10,000,000 copies/mL
21 days - - + + negative not performed
31 days - + + + HIV-1 indeterminate 
gp41++, p31+
not performed
66 days not performed not performed + + HIV-1 positive gp41+++, 
p31++, p24+++, p17+++
1,350 copies/mL
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We describe a case of symptomatic acute HIV infec-
tion in a young man where a fourth-generation rapid 
screening test combining HIV-specific antibody and 
p24 antigen was negative. 
SUMMARY
In highly suspicious cases of acute HIV infection, plas-
ma HIV RNA assays together with conventional, non-
rapid screening tests should be used.
Descriviamo il caso clinico riguardante un giovane ragazzo 
con un’infezione acuta da HIV sintomatica non diagnosti-
cata dal test rapido combo di quarta generazione. Nei casi 
RIASSUNTO
altamente sospetti di infezione acuta da HIV si dovrebbero 
preferire la determinazione di HIV RNA plasmatico e i tests 
di screening convenzionali.
